tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXEL Stock Latest News

Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
Company AnnouncementsPan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
10h ago
BMY
NVS
Exelixis price target lowered to $46 from $53 at H.C. Wainwright
PremiumThe Fly
Exelixis price target lowered to $46 from $53 at H.C. Wainwright
4d ago
EXEL
Exelixis and Merck’s Promising Study on Renal Cell Carcinoma Treatment
PremiumCompany Announcements
Exelixis and Merck’s Promising Study on Renal Cell Carcinoma Treatment
14d ago
EXEL
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
PremiumCompany Announcements
Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
14d ago
BMY
NVS
Exelixis price target lowered to $38 from $43 at UBS
PremiumThe Fly
Exelixis price target lowered to $38 from $43 at UBS
17d ago
EXEL
Exelixis Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsExelixis Earnings Call: Growth Amid Challenges
17d ago
EXEL
Exelixis falls -16.7%
Premium
The Fly
Exelixis falls -16.7%
17d ago
EXEL
Exelixis falls -15.7%
Premium
The Fly
Exelixis falls -15.7%
18d ago
EXEL
Exelixis price target lowered to $46 from $48 at Morgan Stanley
PremiumThe Fly
Exelixis price target lowered to $46 from $48 at Morgan Stanley
18d ago
EXEL
Exelixis price target lowered to $49 from $56 at Truist
PremiumThe Fly
Exelixis price target lowered to $49 from $56 at Truist
18d ago
EXEL
Exelixis price target lowered to $45 from $50 at RBC Capital
PremiumThe Fly
Exelixis price target lowered to $45 from $50 at RBC Capital
18d ago
EXEL
Exelixis’s Cabometyx Gains Strong Market Share in Neuroendocrine Tumors, Exceeding Expectations
PremiumRatings
Exelixis’s Cabometyx Gains Strong Market Share in Neuroendocrine Tumors, Exceeding Expectations
18d ago
EXEL
Exelixis Stock Performance: Hold Rating Amid Earnings Miss and Strategic Concerns
PremiumRatingsExelixis Stock Performance: Hold Rating Amid Earnings Miss and Strategic Concerns
18d ago
EXEL
Exelixis’s Long-Term Growth Potential: Buy Rating Backed by Strong Fundamentals and Promising Drug Pipeline
Premium
Ratings
Exelixis’s Long-Term Growth Potential: Buy Rating Backed by Strong Fundamentals and Promising Drug Pipeline
18d ago
EXEL
Exelixis Reports Q2 2025 Financial Results and Updates
Premium
Company Announcements
Exelixis Reports Q2 2025 Financial Results and Updates
18d ago
EXEL
Closing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause
PremiumThe Fly
Closing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause
18d ago
CR
BRO
Exelixis reports Q2 EPS 75c, consensus 64c
PremiumThe Fly
Exelixis reports Q2 EPS 75c, consensus 64c
18d ago
EXEL
Exelixis still sees FY25 revenue $2.25B-$2.35B, consensus $2.34B
PremiumThe Fly
Exelixis still sees FY25 revenue $2.25B-$2.35B, consensus $2.34B
18d ago
EXEL
Exelixis options imply 6.9% move in share price post-earnings
PremiumThe Fly
Exelixis options imply 6.9% move in share price post-earnings
18d ago
EXEL
Options Volatility and Implied Earnings Moves Today, July 28, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, July 28, 2025
19d ago
WM
CLS
EXEL Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
EXEL Upcoming Earnings Report: What to Expect?
21d ago
EXEL
Pan Tumor Rollover Study: A Key Update for Investors in Cancer Therapies
Premium
Company Announcements
Pan Tumor Rollover Study: A Key Update for Investors in Cancer Therapies
21d ago
BMY
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >